Type
. Tibialis posterior transfer by interosseous route for the correction of foot drop in leprosy. International orthopaedics. 2009;33(6):1637-40.
Type
. Abnormalities in stratum corneum function in patients recovered from leprosy. Skin pharmacology and physiology. 2009;22(3):131-6.
Type
. Mended armor. Nature medicine. 2009;15(1):10-3.
Type
. Leprosy in Sarawak, Borneo: a 5 year review from 2008 to 2012. Leprosy review. 2014;85(4):332-5.
Type
. Proceedings of a joint meeting between the Norwegian Society of Infectious Diseases and the Royal Society of Tropical Medicine and Hygiene, Oslo, 20 June 2008. Transactions of the Royal Society of Tropical Medicine and Hygiene. 2009;103(4):321-4.
Type
. No involvement of non-synonymous TLR2 polymorphisms in Japanese leprosy patients. Journal of dermatological science. 2009;54(1):48-9.
Type
. Antileprosy activity and preliminary toxicological characteristics of some dialkyldithiocarbamate derivatives. Bulletin of experimental biology and medicine. 2008;145(4):446-8.
Type
. Genetic, epidemiological and biological analysis of interleukin-10 promoter single-nucleotide polymorphisms suggests a definitive role for -819C/T in leprosy susceptibility. Genes and immunity. 2009;10(2):174-80.
Type
. Development and validation of a severity scale for leprosy type 1 reactions. PLoS neglected tropical diseases [Internet]. 2008;2(12):e351. Available from: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2596969/pdf/pntd.0000351.pdf
Type
. Anti-cyclic citrullinated peptide antibodies and rheumatoid factor in leprosy patients with articular involvement. Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas. 2008;41(11):1005-10.